2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of thePharmaceutical Continuous Manufacturing Market?
The anticipated increase in numerous persistent illnesses is predicted to boost the expansion of the pharmaceutical continuous manufacturing market. Chronic diseases, broadly defined, are those that last for a year or more, require regular medical care, and affect daily activities. Continuous manufacturing techniques allow pharmaceutical businesses to optimize drug production, which leads to improved efficiency and reduced costs. Crucially, it allows for a wider distribution of necessary medications, key to managing chronic conditions requiring long-term drug use. For instance, a report by the National Association of Chronic Disease Directors (NACDD), a non-profit Public Health organization committed to chronic disease initiatives in the US, showed in April 2022 that nearly 60% of American adults suffer from at least one chronic condition, and about 40% have multiple chronic conditions (MCC). This is predicted to impose a $2 trillion annual burden on the US economy, or $8,600 per individual by 2030. Hence, the rising incidence of several chronic illnesses is expected to fuel the pharmaceutical continuous manufacturing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
#How Does the Projected Pharmaceutical Continuous Manufacturing Market Growth Compare Over the Forecast Period?
In the past few years, the market size of pharmaceutical continuous manufacturing has seen swift expansion. It is projected to increase from a worth of $2.47 billion in 2024 to $2.72 billion in 2025, revealing a compound annual growth rate (CAGR) of 10.2%. Factors such as enhancements in quality and efficiency, diminished time-to-market, cost-saving measures, operational efficiency boosts, supportive regulatory guidelines, and scalability and flexibility have contributed to the growth experienced in the historical period.
The market size for continuous manufacturing in the pharmaceutical sector is projected to witness quick expansion in the upcoming years. By 2029, it is estimated to reach $4.15 billion, with a compound annual growth rate (CAGR) of 11.2%. The surge during the predicted timeframe is due to factors such as the rise in production of generic drugs, biopharmaceutical manufacturing, manufacturing of personalized medicine, and a heightened emphasis on patient-centric approaches. Key patterns for the forecast period comprises the adoption of continuous manufacturing, the incorporation of process analytical technology, the employment of advanced automation and robotics, strategic alliances and partnerships, and the shift towards digitalization and connectivity.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12123
What Key Market Trends and Innovations Are Shaping the Future of thePharmaceutical Continuous Manufacturing Industry?
Technological advancements are currently a predominant trend within the pharmaceutical continuous manufacturing market. Major corporations engaging in this field are creating new products to maintain their market positioning. As an example, the United States Pharmacopeia (USP), a nonprofit organization based in the US holding patents and copyrights over the Pharmacopeia National Formulary (USP-NF), launched the USP Advanced Manufacturing Technology Lab and R&D analytical solutions in December 2022. Such analytical laboratory services can support pharmaceutical businesses in embracing innovative manufacturing technologies, such as pharmaceutical continuous manufacturing (PCM), in order to promote geographical diversity in pharmaceutical production and bolster resilience in the medical supply chain. This will involve detailing materials and constructing and qualifying methods to support and secure the quality of PCM-based drugs.
Which Companies Are Leading the Charge in Expanding thePharmaceutical Continuous Manufacturing Market Growth?
Major companies operating in the pharmaceutical continuous manufacturing market include Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
Order Your Report Now For A Swift Delivery:
How is the Global Pharmaceutical Continuous Manufacturing Market Segemented?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12123&type=smp
Which Geographics are Influencing the Growth of the Pharmaceutical Continuous Manufacturing Market?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Pharmaceutical Continuous Manufacturing Maret 2025, By The Business Research Company:
Styrene Butadiene Rubber (SBR) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/styrene-butadiene-rubber-sbr-global-market-report
Automotive Garage Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/automotive-garage-equipment-global-market-report
Green Tires Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/green-tires-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: